Bedrocan Danmark ApS: Financial statements 2023
CVR: 43238779
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Bedrocan Danmark ApS (CVR 43238779) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,599,674 and a net result of DKK -13,867,739. Equity in the 2023 report amounted to DKK 41,340,664. The solvency ratio was 26.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -2,599,674
- Profit/Loss
- DKK -13,867,739
- Equity
- DKK 41,340,664
- Total Assets
- DKK 154,963,749
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Bedrocan Danmark ApS has published its interim report for the period April 25, 2022 – December 31, 2022.
As of May 30, 2023, Hans Rudolf Spits is registered as director of Bedrocan Danmark ApS.
About Bedrocan Danmark ApS
Bedrocan Danmark ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2022. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Jacob Leendert Erkelens and Hans Rudolf Spits. The company is owned by Bedrocan International B.V.. According to the 2025 annual report, the company had an average of 23 employees. In 2025, the company reported a gross profit of DKK 36,432,443 and a net result of DKK 777,337 compared with DKK 10,182,909 the year before. Equity in the 2025 report amounted to DKK 104,514,389.